| Gregory David Powell, CRNA | |
|
318 Braeburn Glen Dr, Minden, LA 71055-5798 | |
| (318) 245-1725 | |
| Not Available |
| Full Name | Gregory David Powell |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 318 Braeburn Glen Dr, Minden, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639400773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 083219 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Minden Medical Center | Minden, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minden Anesthesia Llc | 1355687757 | 5 |
News Archive
Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill Cornell Medical College in New York City.
Amarantus BioSciences, Inc., a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains.
The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
Results from an Italian study show that greater hippocampal deflation is associated with increased illness severity and poorer social functioning in patients with schizophrenia.
› Verified 4 days ago
| Entity Name | Minden Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710456736 PECOS PAC ID: 1355687757 Enrollment ID: O20190107000024 |
News Archive
Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill Cornell Medical College in New York City.
Amarantus BioSciences, Inc., a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains.
The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
Results from an Italian study show that greater hippocampal deflation is associated with increased illness severity and poorer social functioning in patients with schizophrenia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory David Powell, CRNA 318 Braeburn Glen Dr, Minden, LA 71055-5798 Ph: (318) 245-1725 | Gregory David Powell, CRNA 318 Braeburn Glen Dr, Minden, LA 71055-5798 Ph: (318) 245-1725 |
News Archive
Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill Cornell Medical College in New York City.
Amarantus BioSciences, Inc., a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains.
The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
Results from an Italian study show that greater hippocampal deflation is associated with increased illness severity and poorer social functioning in patients with schizophrenia.
› Verified 4 days ago
Mr. Larry Joe Haley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Medical Plaza Pl, Minden, LA 71055 Phone: 318-377-2321 Fax: 318-371-3219 | |
Philip Jake Killgore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Plaza Pl, Minden, LA 71055 Phone: 318-377-2321 | |
Mr. George Wayne Byram Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Plaza Pl, Minden, LA 71055 Phone: 318-377-2321 | |
Dean Boelter, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Plaza Pl, Minden, LA 71055 Phone: 318-377-2321 |